Clinical Trials Logo

Gastric Variceal Bleeding clinical trials

View clinical trials related to Gastric Variceal Bleeding.

Filter by:
  • None
  • Page 1

NCT ID: NCT05302661 Enrolling by invitation - Liver Cirrhosis Clinical Trials

Effect of Re-education on Rebleeding Rate After Endoscopic Treatment in Liver Cirrhosis

Start date: February 19, 2022
Phase: N/A
Study type: Interventional

A prospective, randomized controlled study on whether re-education after discharge can reduce the rebleeding rate after endoscopic treatment of esophageal and gastric varices in patients with liver cirrhosis

NCT ID: NCT00735358 Completed - Clinical trials for Gastric Variceal Bleeding

Comparison of Endoscopic Injection of Conventional and Double Doses Cyanoacrylate for Gastric Variceal Hemorrhage

Start date: September 2005
Phase: Phase 4
Study type: Interventional

The recent practice guideline recommends endoscopic injection of cyanoacrylate (GVO) is the preferred method to treat acute gastric variceal bleeding. The rebleeding rate remains high following GVO.We hypothesized that a double-dose of cyanoacrylate may obliterate the varices more effectively and achieve better hemostasis.

NCT ID: NCT00567216 Recruiting - Clinical trials for Gastric Variceal Bleeding

Endoscopic Cyanoacrylate Obliteration vs. Nadolol Treatment in the Prevention of Gastric Variceal Rebleeding

GVO-nadolol
Start date: April 2007
Phase: Phase 4
Study type: Interventional

Gastric variceal bleeding has a very high rebleeding rate even after endoscopic variceal injection of cyanoacrylate (GVO) which is considered the first choice of endoscopic treatment. Beta-blocker (BB) is effective to lower portal pressure. We hypothesized combination of GVO and BB can further decrease the rebleeding rate.